Atul Saran Emergent Bio Solutions Inc. (EBS) insider trading activity

Atul Saran is EVP, Chief Strat & Dev Officer of Emergent BioSolutions Inc.. Currently has a direct ownership of 86,645 shares of EBS, which is worth approximately $774,606. The most recent transaction as insider was on Feb 28, 2023, when has been sold 971 shares (Common Stock) at a price of $12.38 per share, resulting in proceeds of $12,020. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.6K

0% 3M change

0% 12M change

Total Value Held $774,606

ATUL SARAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2023	SELL Payment of exercise price or tax liability	$12,020 $12.38 p/Share	971 Reduced 1.11%	86,645 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$11,584 $13.71 p/Share	845 Reduced 0.96%	87,616 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$5,219 $14.3 p/Share	365 Reduced 0.41%	88,461 Common Stock
Feb 08 2023	SELL Payment of exercise price or tax liability	$27,175 $13.25 p/Share	2,051 Reduced 2.26%	88,826 Common Stock
Feb 08 2023	BUY Grant, award, or other acquisition	-	95 Added 0.1%	90,877 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	48,333 Added 34.55%	91,546 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$30,285 $39.64 p/Share	764 Reduced 0.83%	90,782 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$36,397 $42.47 p/Share	857 Reduced 1.94%	43,213 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$18,666 $42.23 p/Share	442 Reduced 0.99%	44,070 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$88,007 $42.23 p/Share	2,084 Reduced 4.47%	44,512 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	1,836 Added 3.79%	46,596 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$151,845 $97.15 p/Share	1,563 Reduced 3.37%	44,760 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$82,926 $93.49 p/Share	887 Reduced 1.88%	46,323 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	7,488 Added 13.69%	47,210 Common Stock
Feb 09 2021	SELL Payment of exercise price or tax liability	$299,983 $123.45 p/Share	2,430 Reduced 5.76%	39,722 Common Stock
Feb 09 2021	BUY Grant, award, or other acquisition	-	2,656 Added 5.93%	42,152 Common Stock

Atul Saran

EVP, Chief Strat & Dev Officer

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Value

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Emergent BioSolutions Inc.

Track Activities on EBS

Account